Kristina Johnson Email

VP Global Head Clinical Development Ops . QurAlis

Current Roles

Employees:
90
Revenue:
$15.7M
About
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
QurAlis Address
100 Cambridgepark Drive
Cambridge, MA
United States
QurAlis Email

Past Companies

QurAlisVice President Clinical Operations
Dyne TherapeuticsExecutive Director, Head of Clinical Operations
bluebird bioSenior Director, Clinical Trial Strategy & Execution (oncology)

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.